Abstract
Molecular diagnostics or the analysis of DNA and RNA at the molecular level -
is a fast-growing market, driven by the growing understanding of the human
genome. Although a small part of the In-Vitro Diagnostics (IVD) market,
molecular diagnostics market is one of the two growth drivers of the IVD
industry.
In the decision making process of healthcare experts, diagnostics tests have a
major influence. Diagnostics tests are a very small percentage cost of medical
expenditures but generally accounts for 60-70% of all treatment decisions. And
with the advent of molecular diagnostics, there is a growing focus on
diagnostics for early detection of diseases.
Molecular diagnostics holds immense business potential as it is based on the
intention of identifying viruses and infectious diseases more accurately at an
earlier stage than currently possible. Molecular diagnostics has also emerged
as a potential business opportunity as diagnostics businesses generally fetch
higher returns of investment than pharmaceutical and other biotech businesses.
The molecular diagnostics industry is growing on the path of continuous
innovation and changing technological base and this is creating new
opportunities and applications. The major factors that will drive the growth
of this industry includes the increasing incidences of various chronic
diseases, increasing number of cases of hepatitis B and tuberculosis and the
availability of various molecular diagnostics tests. Molecular diagnostics or
MDx is the fastest growing segment of the IVD market, also because of the
innovation in the industry resulting in the advent of new technologies for
genetic testing, faster screening and more precise detection.
The report titled “Molecular Diagnostics Industry: Trends and
Opportunities” analyzes the molecular diagnostics segment of IVD
industry. The study explores the potential business opportunities that exist
in the molecular diagnostics industry. Further, factors that are driving the
growth of the industry have been assessed. Also, major industry trends have
been outlined. The report analyzes the level of competition in the molecular
diagnostics industry and also profiles the leading players underlining their
sales and business strategies.
Further, we have predicted the future growth of the molecular diagnostics
industry by combining SPSS Inc.' s data integration and analysis capabilities
with our relevant findings. We employed various significant variables that
have an impact on this industry and created regression models with SPSS to
determine the future direction of the industry.
|